Understanding the mechanisms of drug-associated interstitial lung disease

British Journal of Cancer
T HigenbottamY Fujita

Abstract

Drugs have been implicated in lung injury as a result of direct pharmacological action, persistence or metabolism in the tissue, or via the production of a reactive metabolite or metabolites. The result of this apparent drug-associated injury ranges from cellular dysfunction through to cell death (apoptosis) and alteration of repair mechanisms that are essential in replacing critical tissue elements and function. There is limited knowledge on how timing of drug administration or drug interactions may interfere with the repair mechanisms or modulate the expression of pulmonary toxicity. Chemotherapeutic drugs and novel agents, such as those targeting the epidermal growth factor receptor (EGFR), appear to affect both normal and neoplastic cells. However, unlike chemotherapy, where the actions are systemic and directly as a result of biotransformation or cell injury, it has been postulated that effects of EGFR-targeting agents are more likely to be focused on epithelia via a pharmacological effect. Furthermore, risk factors for the development of adverse pulmonary reactions, as well as biological markers indicating incipient toxicity, need to be prospectively identified. Proteomics, through the identification of >/=1000 proteins o...Continue Reading

References

Jan 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M FukuokaN Masuda
Mar 12, 1991·International Journal of Cancer. Journal International Du Cancer·S AnttilaH Bartsch
Aug 1, 1991·American Journal of Respiratory Cell and Molecular Biology·N KhalilA H Greenberg
Apr 1, 1985·Australian and New Zealand Journal of Medicine·M R BellP G Gill
Jun 23, 1988·The New England Journal of Medicine·A D AckermanM C Rogers
Sep 1, 1988·Journal of the American College of Cardiology·S A MagroC R Wyndham
May 1, 1972·Proceedings of the Society for Experimental Biology and Medicine·A A Marino, J T Mitchell
Jul 1, 1982·Chemico-biological Interactions·D L WarrenA R Buckpitt
Jan 1, 1994·Clinics in Dermatology·W T Lawrence, R F Diegelmann
Jul 1, 1993·The Journal of Clinical Investigation·V A PolunovskyP B Bitterman
May 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H KunitohT Taguchi
Apr 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B ReckzehK Havemann
Aug 1, 1996·American Journal of Respiratory and Critical Care Medicine·K KuwanoN Hara
Feb 1, 1997·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M MeradT Le Chevalier
Oct 6, 1997·American Journal of Respiratory Cell and Molecular Biology·N HagimotoN Hara
Jun 13, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M YamadaJ Yoshikawa
Dec 31, 1998·American Journal of Respiratory Cell and Molecular Biology·K KuwanoN Hara
May 5, 1999·American Journal of Respiratory Cell and Molecular Biology·R PolosaD E Davies
Jul 7, 1999·The Journal of Clinical Investigation·K KuwanoN Hara
Jul 6, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S M PuddicombeD E Davies
Jun 29, 2001·Current Opinion in Oncology·S H AbidM C Perry
Nov 1, 2001·Respiratory Research·H Fehrenbach
Nov 27, 2001·British Journal of Cancer·G S WangR P Perng
May 23, 2002·Seminars in Liver Disease·Neil Kaplowitz
Jun 11, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Naoki HagimotoNobuyuki Hara
Dec 14, 2002·Laboratory Investigation; a Journal of Technical Methods and Pathology·Kazuyoshi KuwanoNobuyuki Hara
Jan 18, 2003·Lancet·Akira InoueToshihiro Nukiwa
Aug 9, 2003·Critical Care Medicine·David W ShimabukuroMichael A Gropper
Jan 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lijo SimpsonAgnes Piotrowski

❮ Previous
Next ❯

Citations

Sep 17, 2005·American Journal of Respiratory Cell and Molecular Biology·Patrizia RussoLorenzo Dominioni
Nov 11, 2011·Expert Opinion on Drug Metabolism & Toxicology·Martin SchwaiblmairThomas Berghaus
Apr 1, 2006·Current Medical Research and Opinion·Keunchil Park, Koichi Goto
Jul 17, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Akira OnoNobuyuki Yamamoto
Jul 26, 2013·World Journal of Surgical Oncology·Tomomi YakabeHirokazu Noshiro
Aug 7, 2007·Internal Medicine·Yuji TadaTakayuki Kuriyama
Mar 1, 2019·Medicine·Ping ZhangGuifang Ouyang
Mar 22, 2018·Molecular Cancer·Ruihao ZhouGuofu Huang
Jan 15, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·So Young ParkGee Young Suh
Dec 12, 2018·Current Cancer Drug Targets·Tatsuya NaganoYoshihiro Nishimura
Jan 19, 2016·Respirology : Official Journal of the Asian Pacific Society of Respirology·Tsuyoshi HamadaKazuhiko Koike
Mar 16, 2016·Wiener klinische Wochenschrift·Ozge GumusayAhmet Ozet
Jan 1, 2009·Der Pneumologe·J Schreiber
Jan 1, 2018·Der Pneumologe·J Schreiber, U Müller-Ladner
Jan 9, 2021·The Korean Journal of Internal Medicine·Min-Young LeeJong-Ho Won
Mar 23, 2021·World Journal of Clinical Cases·Do-Sik MoonYong-Sub Na

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging techniques
electrophoresis
lavage
chip
chips

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis